MIA
MRNA icon

MMBG Investment Advisors’s Moderna MRNA Stock Holding History

MMBG Investment Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,860
Closed -$340K – 169
2024
Q2 		$340K Hold
2,860
– – 0.04% 130
2024
Q1 		$305K Hold
2,860
– – 0.03% 147
2023
Q4 		$284K Hold
2,860
– – 0.03% 146
2023
Q3 		$295K Hold
2,860
– – 0.04% 137
2023
Q2 		$352K Hold
2,860
– – 0.04% 133
2023
Q1 		$439K Hold
2,860
– – 0.06% 123
2022
Q4 		$514K Sell
2,860
-1,430
-33% -$234K 0.07% 115
2022
Q3 		$507K Hold
4,290
– – 0.07% 116
2022
Q2 		$613K Buy
4,290
+1,430
+50% +$204K 0.08% 107
2022
Q1 		$493K Hold
2,860
– – 0.05% 122
2021
Q4 		$726K Buy
+2,860
New +$836K 0.07% 111

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

MMBG Investment Advisors's MRNA Position: Q3 2024 in Review

MMBG Investment Advisors sold out of Moderna (MRNA) in Q3 2024, closing a stake of 2,860 shares — an estimated $340K sold.

MMBG Investment Advisors first reported a position in MRNA in Q4 2021 and held it in 11 quarters. The position peaked at $726K in Q4 2021. 788 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.

  • MMBG Investment Advisors reported no remaining Moderna position as of Q3 2024 after selling out during the quarter.
  • MMBG Investment Advisors sold 2,860 Moderna shares in Q3 2024, an estimated $340K.
  • MMBG Investment Advisors first reported a position in Moderna in Q4 2021 and held it in 11 quarters.
  • MMBG Investment Advisors's Moderna position peaked at $726K in Q4 2021.
  • 788 funds tracked by Wall St. Rank held Moderna as of Q3 2024.

Based on MMBG Investment Advisors's 13F filing for Q3 2024, filed 13 Nov 2024.